ImpediMed

06/15/2026

What can a 30-second scan tell you? More than you'd think.

SOZO is the only FDA-cleared bioimpedance spectroscopy (BIS) platform that non-invasively measures fluid status and tissue composition, turning a single rapid scan into detailed, objective data clinicians can act on across the patient journey.

How does it work? Can patients feel it? What exactly is BIS?

Swipe through for answers to the questions we hear most.

Explore the full FAQ: https://www.impedimed.com/support/frequently-asked-questions/

06/11/2026

Surviving breast cancer is just the beginning. What comes after — the weight changes, the swelling, the exhaustion — can feel like a second battle no one prepared you for.

American Society of Clinical Oncology's latest guidance on breast cancer survivorship confirms that recovery has to go deeper than "treatment complete." It means watching for lymphedema. It means managing weight and muscle changes that treatment can trigger. It means caring for the whole body, throughout survivorship.

The SOZO Digital Health Platform was built for exactly this. One 30-second scan gives your care team:

• Early lymphedema detection — catching fluid changes before symptoms appear
• BodyComp™ insights — tracking muscle mass, fat mass, and cellular health so your team can tailor lifestyle and weight management support to you

And for patients on GLP-1 therapies, SOZO helps ensure that weight loss is coming from fat — not the muscle mass survivors need most.

You deserve survivorship care that sees the full picture.

06/09/2026

Survivorship doesn't end at the last treatment, and for many breast cancer survivors, the next risk is lymphedema.

The good news: it's preventable, when detected at its earliest stage.

Too often, lymphedema is caught only after symptoms appear, when it becomes a lifelong, chronic condition that is costly and negatively impacts quality of life. Proactive care flips that: a baseline measurement before treatment, routine checks to catch subclinical changes, and brief, targeted intervention the moment those changes show up, before it becomes chronic.

A repeatable pathway that fits existing workflows and aligns with NCCN guidelines and NAPBC standards, without adding complexity.

Swipe through to see how the Lymphedema Prevention Program moves from screening to action.

https://www.impedimed.com/products/programs/lymphedema-prevention-program/

06/07/2026

Today is National Cancer Survivors Day, a global Celebration of Life honoring the more than 18 million people in the U.S. living with a history of cancer.

Survivorship doesn't end when treatment does. Long-term effects like lymphedema can persist for years, which is why survivorship care has to extend well beyond the final treatment.

Recognizing survivors means investing in what comes next: earlier detection, proactive monitoring, and care that protects long-term quality of life.

https://ncsd.org

06/04/2026

This Saturday, we're proud to sponsor THE SIX, the signature production of the Curtain Up Cancer Foundation, as it marks its 10th anniversary.

Each year, THE SIX transforms the real stories of six people affected by cancer into a live performance of storytelling, song, and dance, honoring diagnosis, treatment, caregiving, and survival.

We're honored to stand with the survivors, caregivers, and artists who make this celebration possible.

https://www.curtainupcancerfoundation.org

Curtain Up Cancer Foundation is a 501c3 nonprofit organization providing programs to ease the effects of cancer through the creative arts.

06/03/2026

June is National Cancer Survivorship Month in the U.S.

There are more than 18 million cancer survivors in the U.S. today, a number expected to reach 26 million by 2040.

Survivorship is growing, but surviving cancer is only part of the story. Managing long-term effects like lymphedema, staying ahead of complications, and protecting quality of life: that's where survivorship care has to keep up.

All month, we're focused on what it takes to support survivors beyond their final treatment: earlier detection, proactive care, and the data to back it up.

Learn more: https://cancercontrol.cancer.gov/ocs/about/survivorship-month

05/28/2026

We’re at ACSM Annual Meeting 2026 this week in Salt Lake City.

A big part of the conversation here is how technology is changing the way we measure health, performance, and recovery.

But in practice, a lot of decisions are still based on weight alone.

That’s where things break down. Weight can change without meaningful shifts in body composition, and in many cases, body composition is changing while weight stays the same.

We’re here talking with teams about how they’re using more precise body composition and fluid data to get a clearer picture.

Find us here:

📍 ACSM Annual Meeting 2026 | Salt Lake City, UT | May 26–29 | Booth 704

If you’d like to connect or schedule time:
🔗 https://www.impedimed.com/about/contact/

05/26/2026

Early detection only works when it’s part of a consistent approach—baseline measurement, routine monitoring, and a plan for when something changes.

That’s the idea behind a Lymphedema Surveillance Program. When lymphedema is caught at the subclinical stage, it can be resolved. Once it progresses, it becomes a lifelong condition and difficult to manage.

In practice, keeping that kind of approach is managed day to day by oncology nurses—making sure patients are routinely monitored and detected early for intervention.

Learn more about implementing an evidence-based Lymphedema Surveillance Program:
🔗 https://www.impedimed.com/solutions/lymphedema-prevention-program/

05/21/2026

Because heart failure needs more than a scale.

During Heart Failure Awareness Month, there’s a lot of focus on “seeing the whole picture”—especially as care becomes more connected across conditions, settings, and time.

In one case, an 87-year-old patient with NYHA II–III heart failure was monitored following discharge. While things appeared clinically stable, HF-Dex® remained elevated (>51%) for nearly 100 days, aligning with two subsequent readmissions.

Weight remained largely unchanged during that time, even as HF-Dex® stayed elevated.

The issue wasn’t showing up on the scale—it was showing up in extracellular fluid, which is easy to miss if weight is the only measure being used.

—

See how fluid insights revealed what traditional monitoring missed in this case:
🔗 https://www.impedimed.com/solutions/heart-health-management/

05/18/2026

In wellness, results matter—but they're not always easy to prove.

Clients can be losing weight without improving body composition. They can feel different without seeing it clearly reflected. And when progress isn't obvious, it's harder to keep people engaged.

At CryoCON 2026 in DFW last week, that's the kind of conversation we had with wellness operators—how to bring more objective insight into consultations, treatment plans, and long-term client retention.

It was great connecting with teams about what that looks like in practice.
—
If you'd like to connect or learn more: 🔗 https://www.impedimed.com/about/contact/